Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Current Assets:
Cash and cash equivalents	$ 44,579	$ 18,998
Accounts receivable, net of allowances of $206 and $81 as of June 30, 2023 and September 30, 2022, respectively	11,752	10,452
Contract assets — royalties and license fees	7,678	7,116
Inventories, net	14,610	11,819
Income tax receivable		2,438
Prepaids and other	7,231	6,764
Total Current Assets	85,850	57,587
Property and equipment, net	26,571	27,148
Intangible assets, net	27,798	28,145
Goodwill	43,844	40,710
Other assets	4,838	4,769
Total Assets	188,901	158,359
Current Liabilities:
Accounts payable	2,484	3,136
Accrued liabilities:
Compensation	7,830	8,929
Accrued other	5,453	5,854
Short-term borrowings		10,000
Deferred revenue	4,328	4,160
Income tax payable	11,953
Total Current Liabilities	32,048	32,079
Long-term debt, net	29,353
Deferred revenue, less current portion	3,492	5,088
Deferred income taxes	2,057	2,027
Other long-term liabilities	9,539	10,773
Total Liabilities	76,489	49,967
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Series A Preferred stock - $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock --$.05 par value, 45,000 shares authorized: 14,134 and 14,029 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively	707	701
Additional paid-in capital	34,345	28,774
Accumulated other comprehensive loss	(3,201)	(9,874)
Retained earnings	80,561	88,791
Total Stockholders’ Equity	112,412	108,392
Total Liabilities and Stockholders’ Equity	$ 188,901	$ 158,359